More Citation Vigilance

More Citation Vigilance We find the recent dialogue regarding citation vigilance and the disregard syndrome1 both stimulating and invaluable, and could not agree with you more. In fact, we found the topic so compelling, we have written an education/research case study to assist graduate students in developing good literature reviews, which is based in part on articles in The Scientist. Further, we believe Ginsburg's opinion piece will serve as an excellent case study in and of itself. In rev

Written byValerie Askren
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

We find the recent dialogue regarding citation vigilance and the disregard syndrome1 both stimulating and invaluable, and could not agree with you more. In fact, we found the topic so compelling, we have written an education/research case study to assist graduate students in developing good literature reviews, which is based in part on articles in The Scientist.

Further, we believe Ginsburg's opinion piece will serve as an excellent case study in and of itself. In reviewing Ginsburg's cited references we observed the following:

In reference 2, The Journal of Leukemia Biology does not exist. The manuscript was published in the Journal of Leukocyte Biology. Furthermore, the manuscript was published in 1998, Volume 64, Issue 1, and encompasses pages 14-18.

In reference 5, the pages actually run from 555-64.

In reference 6, the word "acid" should be plural, as originally published.

Although these examples are minor, they prove disconcerting for the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies